Staphylococcus aureus infections in pediatric patients with diabetes mellitus

Erin N Menne1, Rona Yoffe Sonabend, Edward O Mason

  • 1Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.

Insights

Children with diabetes mellitus (DM) experiencing Staphylococcus aureus infections often have poor glycemic control and recurrent infections. Improving blood sugar management may lower the risk and incidence of these serious bacterial infections.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Endocrinology

Background:

  • Staphylococcus aureus infections pose a significant health risk, particularly in vulnerable populations.
  • Children with diabetes mellitus (DM) may have altered susceptibility to infections.
  • Understanding the specific challenges of S. aureus infections in pediatric DM is crucial for effective management.

Purpose of the Study:

  • To characterize Staphylococcus aureus infections in children with diabetes mellitus.
  • To identify risk factors and clinical features associated with these infections.
  • To compare infection patterns in diabetic children to a non-diabetic control group.

Main Methods:

  • Retrospective review of a surveillance database for S. aureus infections in children with DM.
  • Molecular characterization of S. aureus isolates.
  • Comparison of cases (children with DM and S. aureus infection) to age-matched controls using conditional logistic regression.

Main Results:

  • Forty-seven cases of S. aureus infection in children with DM were identified.
  • Poor glycemic control (HbA1c > 10%) was prevalent in cases.
  • Cases showed higher rates of recurrent infections and were more likely to be female compared to controls.
  • Methicillin-resistant S. aureus (MRSA) was common, particularly in recurrent infections.

Conclusions:

  • Children with DM and S. aureus infections frequently exhibit poor glycemic control and increased recurrence rates.
  • Female gender and recurrent infections were more common in the diabetic cohort.
  • Enhanced glycemic control in pediatric diabetes may mitigate the risk and burden of S. aureus infections.
Abstract

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...